首页|不同分割放射治疗模式对早期乳腺癌保乳术后患者免疫功能的影响

不同分割放射治疗模式对早期乳腺癌保乳术后患者免疫功能的影响

扫码查看
目的 探讨不同分割放射治疗(放疗)模式对早期乳腺癌保乳术后患者免疫功能的影响.方法 选取110例早期乳腺癌保乳术后患者,使用随机数表法分为观察组与对照组,每组55例.对照组患者接受常规分割的放疗模式,观察组患者接受短程大分割的放疗模式.比较两组患者危及器官(OAR)所受剂量、治疗前后免疫功能(淋巴细胞与单核细胞的比值)、急性放疗的不良反应发生率.结果 观察组患者患侧肺接受5 Gy剂量照射的肺体积占全肺总体积的百分比(V5)、接受10 Gy剂量照射的肺体积占全肺总体积的百分比(V10)、接受20 Gy剂量照射的肺体积占全肺总体积的百分比(V20)、平均剂量以及健侧肺V5、V10、平均剂量分别为(54.25±10.54)%、(28.04±9.65)%、(15.04±4.65)%、(1008.65±165.57)cGy、(3.88±1.02)%、(0.15±0.02)%、(196.35±31.49)cGy,均低于对照组的(70.68±12.32)%、(35.68±9.61)%、(17.51±3.58)%、(1305.47±188.34)cGy、(7.65±2.02)%、(0.99±0.14)%、(239.65±85.47)cGy,差异具有统计学意义(P<0.05).治疗前,观察组患者淋巴细胞与单核细胞的比值为(3.11±1.02),对照组为(3.36±1.20);治疗后,观察组患者淋巴细胞与单核细胞的比值为(1.92±0.34),对照组为(1.90±0.28).治疗前,两组患者淋巴细胞与单核细胞的比值比较差异无统计学意义(P>0.05).治疗后,两组患者淋巴细胞与单核细胞的比值均较治疗前降低,差异具有统计学意义(P<0.05).治疗后,两组淋巴细胞与单核细胞的比值比较差异无统计学意义(P>0.05).两组患者急性放疗的不良反应发生率比较差异无统计学意义(P>0.05).结论 对早期乳腺癌保乳术后患者进行短程大分割的放疗模式干预,不仅可以有效减少部分危及器官所受剂量水平,效果确切,还不会增加免疫抑制及放疗后不良反应风险,具有较高的安全性,值得推广应用.
Effect of different fractionated radiotherapy modes on immune function of early breast cancer patients after breast conserving surgery
Objective To explore the effect of different fractionated radiotherapy modes on immune function of early breast cancer patients after breast conserving surgery. Methods A total of 110 cases of early breast cancer patients after breast conserving surgery were divided into an observation group and a control group according to random numerical table,with 55 patients in each group. Patients in the control group received the conventional fractionation radiotherapy,while patients in the observation group received the short-range and large-division radiotherapy. Both groups of patients were compared in terms of the organ-at-risk (OAR) dose,immune function (ratio of lymphocytes to monocytes) before and after treatment,and the incidence of adverse reactions to acute radiotherapy. Results In the observation group,the percent volume receiving at least 5 Gy (V5),percent volume receiving at least 10 Gy (V10),percent volume receiving at least 20 Gy (V20),average dose of the affected lung,and V5,V10,average dose of the healthy lung were (54.25±10.54)%,(28.04±9.65)%,(15.04±4.65)%,(1008.65±165.57) cGy and (3.88±1.02)%,(0.15±0.02)%,(196.35±31.49) cGy,which were lower than (70.68±12.32)%,(35.68±9.61)%,(17.51±3.58)%,(1305.47±188.34) cGy and (7.65±2.02)%,(0.99±0.14)%,(239.65±85.47) cGy in the control group;the difference was statistically significant (P<0.05). Before treatment,the ratio of lymphocyte to monocyte was (3.11±1.02) in the observation group and (3.36±1.20) in the control group;after treatment,the ratio of lymphocytes to monocytes was (1.92±0.34) in the observation group and (1.90±0.28) in the control group. Before treatment,there was no significant difference in ratio of lymphocyte to monocyte between the two groups (P>0.05). After treatment,the ratio of lymphocytes to monocytes in both groups was lower than that before treatment,and the difference was statistically significant (P<0.05). After treatment,there was no significant difference in ratio of lymphocyte to monocyte between the two groups (P>0.05). There was no significant difference in the incidence of adverse reactions to acute radiotherapy between the two groups (P>0.05). Conclusion Short-range and large-division radiotherapy can effectively reduce the dose levels received by some organs at risk,but also does not increase the risk of immunosuppression and adverse reactions after radiotherapy,which has a high safety and is worthy of promotion and application.

RadiotherapyBreast cancerEarly stageBreast conserving surgeryImmune function

黄明英、莫月媚、邝碧茹、余健

展开 >

526040 肇庆市第一人民医院乳腺内科

放射治疗 乳腺癌 早期 保乳术 免疫功能

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(20)